A detailed history of Lgt Fund Management CO Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lgt Fund Management CO Ltd. holds 17,018 shares of BMY stock, worth $905,187. This represents 0.09% of its overall portfolio holdings.

Number of Shares
17,018
Holding current value
$905,187
% of portfolio
0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$40.25 - $52.99 $684,974 - $901,783
17,018 New
17,018 $706,000
Q4 2022

Feb 09, 2023

BUY
$68.48 - $81.09 $10,682 - $12,650
156 Added 0.78%
20,156 $1.45 Million
Q3 2022

Oct 19, 2022

SELL
$0.13 - $76.84 $3,977 - $2.35 Million
-30,598 Reduced 60.47%
20,000 $1.42 Million
Q2 2022

Aug 03, 2022

BUY
$72.62 - $79.98 $180,315 - $198,590
2,483 Added 5.16%
50,598 $3.9 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $2.96 Million - $3.55 Million
48,115 New
48,115 $3.55 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lgt Fund Management CO Ltd. Portfolio

Follow Lgt Fund Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Fund Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Lgt Fund Management CO Ltd. with notifications on news.